CYRX

Elite Trades From Anywhere Elite Trades All Summer

$100 Off Your First Year Get Elite For Just $199.50

Days

Hours

Mins

Sec

Claim Now

Peers: FWRD HUBG LSTR CHRW EXPD JBHT UPS ARCB KNX XPO

| Held by: VTI IWM VXF IWN VTWO SCHA DFAS DFMC VHT DFAC

Scroll to Statements

Index	RUT
Market Cap	780.73M
Enterprise Value	651.86M
Income	-44.10M
Sales	182.94M
Book/sh	8.98
Cash/sh	8.01
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	738
IPO	Jan 31, 2005

P/E	-
Forward P/E	-
PEG	-
P/S	4.27
P/B	1.73
P/C	1.93
P/FCF	-
EV/EBITDA	-
EV/Sales	3.56
Quick Ratio	2.00
Current Ratio	2.09
Debt/Eq	0.47
LT Debt/Eq	0.08
Option/Short	Yes / Yes

EPS (ttm)	-0.88
EPS next Y	-0.65
EPS next Q	-0.19
EPS this Y	-155.63%
EPS next Y	15.98%
EPS next 5Y	-
EPS past 3/5Y	-0.23% 13.68%
Sales past 3/5Y	-9.45% 17.49%
EPS Y/Y TTM	62.35%
Sales Y/Y TTM	-14.85%
EPS Q/Q	18.15%
Sales Q/Q	16.47%
Earnings	May 04 AMC
EPS/Sales Surpr.	-15.79% 6.54%

Insider Own	4.47%
Insider Trans	-11.32%
Inst Own	90.28%
Inst Trans	2.32%
ROA	-5.01%
ROE	-8.20%
ROIC	-6.74%
Gross Margin	40.30%
Oper. Margin	-21.41%
Profit Margin	-24.11%
SMA20	1.35%
SMA50	12.10%
SMA200	48.42%
Trades

Shs Outstand	50.20M
Shs Float	48.15M
Short Float	4.56%
Short Ratio	2.85
Short Interest	2.20M
52W High	16.73 -7.41%
52W Low	6.69 131.54%
Volatility	4.99% 4.55%
ATR (14)	0.72
RSI (14)	56.41
Beta	1.89
Rel Volume	0.72
Avg Volume	771.84K
Volume	556,530

Perf Week	-2.46%
Perf Month	-1.59%
Perf Quarter	82.02%
Perf Half Y	60.68%
Perf YTD	61.35%
Perf Year	108.20%
Perf 3Y	-10.20%
Perf 5Y	-74.85%
Perf 10Y	811.18%
Recom	1.22
Target Price	15.61
Prev Close	15.86
Price	15.49
Change	-2.33%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-06-25	Upgrade	Leerink Partners	Market Perform → Outperform	$16
Aug-06-25	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Jul-22-25	Resumed	Stephens	Overweight	$13
Mar-24-25	Upgrade	UBS	Neutral → Buy	$10
Dec-19-24	Initiated	Guggenheim	Buy	$11
Aug-07-24	Downgrade	Jefferies	Buy → Hold	$20 → $8
Jul-31-24	Upgrade	B. Riley Securities	Neutral → Buy	$19 → $15
May-03-24	Downgrade	B. Riley Securities	Buy → Neutral	$22 → $19
Apr-04-24	Resumed	Jefferies	Buy	$17 → $21
Mar-13-24	Reiterated	Needham	Buy	$19 → $18
Aug-17-23	Initiated	Morgan Stanley	Equal-Weight	$16
Aug-10-23	Downgrade	Stephens	Overweight → Equal-Weight	$15
Jul-18-23	Downgrade	UBS	Buy → Neutral	$28 → $17
Jul-17-23	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Jul-13-23	Downgrade	SVB Securities	Outperform → Market Perform	$30 → $10
Jan-19-22	Upgrade	ROTH Capital	Neutral → Buy	$90
Nov-05-21	Downgrade	ROTH Capital	Buy → Neutral	$78 → $90
Oct-19-21	Resumed	B. Riley Securities	Buy	$81
Jul-16-21	Initiated	BTIG Research	Buy	$80
Mar-15-21	Initiated	UBS	Buy	$84

Show Previous Ratings

Jun-25-26 08:00AM	Cryoport's IntegriCell Cryopreservation Services Selected by Verismo Therapeutics to Support Clinical KIR-CAR T Cell Therapy Programs (PR Newswire)
May-04-26 08:23PM	Cryoport, Inc. Q1 2026 Earnings Call Summary (Moby) +19.39%
04:05PM	Cryoport Reports First Quarter 2026 Financial Results (PR Newswire)
Apr-20-26 04:05PM	Cryoport to Report First Quarter 2026 Financial Results on May 4, 2026 (PR Newswire)
Mar-04-26 08:30AM	Cryoport, Inc. Q4 2025 Earnings Call Summary (Moby)
12:00AM	Loading…
12:00AM	CryoPort Inc (CYRX) Q4 2025 Earnings Call Highlights: Record Growth in Cell and Gene Therapy Revenue (GuruFocus.com)
Mar-03-26 07:02PM	CryoPort Q4 Earnings Call Highlights (MarketBeat)
05:25PM	CryoPort, Inc. (CYRX) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Cryoport Reports Fourth Quarter and Full-Year 2025 Financial Results (PR Newswire)
Feb-18-26 08:10AM	Bausch + Lomb (BLCO) Lags Q4 Earnings Estimates (Zacks)
Feb-17-26 08:00AM	Cryoport to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026 (PR Newswire)
Feb-11-26 08:30AM	Cryoport's MVE Biological Solutions Introduces New Fusion 800 Series (PR Newswire)
08:16AM	EXCLUSIVE: New Fusion 800 Launch Signals Cryoport's Ambition To Modernize Cryogenic Storage (Benzinga)
Nov-05-25 12:09AM	CryoPort Inc (CYRX) Q3 2025 Earnings Call Highlights: Double-Digit Growth and Strategic ... (GuruFocus.com) -7.48%
Nov-04-25 05:50PM	CryoPort, Inc. (CYRX) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Loading…
04:05PM	Cryoport Reports Third Quarter 2025 Financial Results (PR Newswire)
Nov-03-25 08:01AM	Earnings To Watch: CryoPort Inc (CYRX) Reports Q3 2025 Result (GuruFocus.com)
Oct-30-25 08:30AM	Cryoport Continues to Set New Benchmarks for the Global Regenerative Medicine Supply Chain (PR Newswire)
Oct-21-25 08:00AM	Cryoport to Report Third Quarter 2025 Financial Results on November 4, 2025 (PR Newswire)
Oct-17-25 04:09AM	CryoPort (CYRX) Moves 7.0% Higher: Will This Strength Last? (Zacks) -5.51%
Oct-07-25 08:30AM	MVE Biological Solutions, A Cryoport Company, Introduces Real-Time Integrated Condition Monitoring Systems For Cryogenic Dewars (PR Newswire)
Oct-01-25 08:30AM	Cryoport Systems Expands Global Footprint with New Global Supply Chain Center in Paris, France (PR Newswire)
Aug-06-25 03:32AM	CryoPort Inc (CYRX) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid Strategic ... (GuruFocus.com) +29.82%
Aug-05-25 06:35PM	CryoPort, Inc. (CYRX) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -5.87%
04:19PM	Cryoport Reports Second Quarter 2025 Financial Results (PR Newswire)
Aug-04-25 05:55PM	Freightcar America (RAIL) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
10:02AM	Earnings To Watch: CryoPort Inc (CYRX) Reports Q2 2025 Result (GuruFocus.com)
Jul-31-25 05:25PM	Hub Group (HUBG) Beats Q2 Earnings Estimates (Zacks)
10:00AM	DHL Group Sponsored ADR (DHLGY) Earnings Expected to Grow: Should You Buy? (Zacks)
Jul-29-25 10:00AM	CryoPort, Inc. (CYRX) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
09:55AM	Loading…
Jul-25-25 09:55AM	CryoPort, Inc. (CYRX) Just Flashed Golden Cross Signal: Do You Buy? (Zacks)
Jul-22-25 08:00AM	Cryoport to Report Second Quarter 2025 Financial Results on August 5, 2025 (PR Newswire) +10.73%
Jul-08-25 08:00AM	Cryoport's MVE Biological Solutions Introduces Next Generation Vapor Shippers (PR Newswire)
07:45AM	EXCLUSIVE: Cryoport Boosts Cold Chain Tech With New Shippers Designed For Delays And Rough Handling (Benzinga)
Jul-04-25 12:00PM	What Makes CryoPort, Inc. (CYRX) a Strong Momentum Stock: Buy Now? (Zacks)
Jun-27-25 12:00PM	CryoPort (CYRX) Upgraded to Buy: Here's What You Should Know (Zacks)
Jun-12-25 08:00AM	Cryoport Completes CRYOPDP Divestiture and Commences Strategic Partnership with DHL Group (PR Newswire)
May-28-25 09:55AM	Wall Street Analysts Believe CryoPort (CYRX) Could Rally 81.43%: Here's is How to Trade (Zacks)
May-12-25 09:55AM	Does CryoPort (CYRX) Have the Potential to Rally 54.74% as Wall Street Analysts Expect? (Zacks)
May-08-25 03:34AM	CryoPort Inc (CYRX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com) +23.32%
May-07-25 07:15PM	Cryoport outlines 2025 revenue guidance and highlights DHL partnership for growth (Seeking Alpha)
07:15PM	Cryoport, Inc. (CYRX) Q1 2025 Earnings Call Transcript (Seeking Alpha)
05:20PM	CryoPort, Inc. (CYRX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Cryoport Reports First Quarter 2025 Financial Results (PR Newswire)
May-06-25 09:35AM	Expeditors International (EXPD) Q1 Earnings and Revenues Surpass Estimates (Zacks)
Apr-30-25 10:01AM	CryoPort, Inc. (CYRX) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Apr-24-25 08:30AM	Cryoport to Report First Quarter 2025 Financial Results on May 7, 2025 (PR Newswire) +5.37%
Apr-10-25 10:39AM	C.H. Robinson (CHRW) Surges 5.7%: Is This an Indication of Further Gains? (Zacks)
Apr-04-25 06:03AM	UBS Says Its Time to Go Bargain Hunting; Here Are 2 Stocks Poised for a Rebound (TipRanks)
Mar-31-25 03:11PM	Cryoport, Inc. (CYRX) Strategic Agreement and Transaction with DHL Group Call (Transcript) (Seeking Alpha)
09:06AM	DHL Group acquires CRYOPDP from Cryoport to strengthen 'DHL Health Logistics' (PR Newswire)
08:09AM	Cryoport to Host Investor Call to Discuss Recent Strategic Agreement and Transformative Transaction Today, March 31, 2025, at 8:30 a.m. ET (PR Newswire)
Mar-26-25 09:15AM	A Deep Look At Cryoport's Dead Cat Bounce (SeekingAlpha)
Mar-18-25 07:59PM	Is Cryoport, Inc. (CYRX) a Pump and Dump Stock Favored by Hedge Funds? (Insider Monkey) -5.35%
Mar-13-25 07:28AM	CryoPort (CYRX) Surges 5.9%: Is This an Indication of Further Gains? (Zacks) -11.36%
Mar-12-25 08:30AM	Cryoport's MVE Biological Solutions Expands High-Efficiency Cryogenic Freezer Series With Answer to Evolving Needs of Fertility Clinics, Biorepositories and Clinical Laboratories (PR Newswire) +5.86%
Mar-05-25 02:10AM	CryoPort Inc (CYRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges (GuruFocus.com) +30.63%
Mar-04-25 05:35PM	CryoPort, Inc. (CYRX) Reports Q4 Loss, Tops Revenue Estimates (Zacks) +5.53%
04:10PM	Cryoport Reports Fourth Quarter and Full Year 2024 Financial Results (PR Newswire)
Mar-03-25 07:18AM	CryoPort Inc (CYRX) Q4 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com) -13.91%
Feb-18-25 08:30AM	Cryoport to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025 (PR Newswire)
Jan-21-25 08:30AM	Cryoport Unveils State-of-the-Art Cryogenic Shipping System for Transporting Lifesaving Biologics and Temperature-Sensitive Therapies (PR Newswire) +8.80%
Jan-14-25 08:30AM	Moffitt Cancer Center and Cryoport Announce Strategic Collaboration (PR Newswire) -10.73%
Jan-06-25 08:30AM	Cryoport's MVE Biological Solutions Registers All Manufacturing Facilities with the U.S. Food and Drug Administration ('FDA') (PR Newswire)
Nov-12-24 08:30AM	Cryoport Expands IntegriCell Cryopreservation Services Solution with Opening of New Center of Excellence in Europe (PR Newswire)
Nov-08-24 04:03PM	CryoPort Inc (CYRX) Q3 2024 Earnings Call Highlights: Strong Service Growth Amid Market Challenges (GuruFocus.com)
Nov-07-24 05:55PM	CryoPort, Inc. (CYRX) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Cryoport Reports Third Quarter 2024 Financial Results (PR Newswire)
Nov-06-24 07:37AM	CryoPort Inc (CYRX) Q3 2024: Everything You Need to Know Ahead of Earnings (GuruFocus.com)
Oct-31-24 10:01AM	CryoPort, Inc. (CYRX) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Oct-29-24 08:30AM	Cryoport to Report Third Quarter 2024 Financial Results on November 7, 2024 (PR Newswire)
Oct-22-24 08:30AM	Cryoport and Gulf Coast Regional Blood Center Launch Strategic Alliance to Enhance Cellular Therapy Services (PR Newswire)
Oct-21-24 08:30AM	TMRW Life Sciences and Cryoport Systems Form Strategic Partnership to Elevate Standards for Frozen Egg, Embryo, and Sperm Offsite Storage and Biologistics (PR Newswire)
Oct-15-24 08:30AM	VGXI Selects Cryoport for Biostorage, Bioservices and Supply Chain Solutions to Advance Next-Generation Therapies (PR Newswire)
Oct-07-24 08:30AM	Cryoport Launches its IntegriCell Cryopreservation Solution with Opening of New Facility at its Houston Campus (PR Newswire)
Sep-25-24 08:30AM	SK pharmteco and Cryoport Partner for Cell and Gene Therapy Logistics and BioServices (PR Newswire)
Sep-09-24 05:28AM	Should You Hold Cryoport (CYRX)? (Insider Monkey) -5.75%
Aug-19-24 03:27AM	Should You be Optimistic on the Growth Prospects of CryoPort (CYRX)? (Insider Monkey)
Aug-06-24 07:00PM	CryoPort, Inc. (CYRX) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
04:15PM	Cryoport Reports Second Quarter 2024 Financial Results (PR Newswire)
04:05PM	Cryoport Announces $200 Million Repurchase Program and the Repurchase of $160 Million of Convertible Senior Notes (PR Newswire)
Jul-23-24 08:30AM	Cryoport to Report Second Quarter 2024 Financial Results on August 6, 2024 (PR Newswire) -5.54%
Jul-12-24 02:46AM	CryoPort (CYRX) Moves 26.7% Higher: Will This Strength Last? (Zacks)
Jul-09-24 09:35AM	CryoPort (CYRX) Loses -43.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks) -5.51%
Jun-20-24 08:30AM	Cryoport and Minaris Regenerative Medicine Form Strategic Partnership to Support Advancement of Cell and Gene Therapies (PR Newswire)
May-17-24 02:33AM	Insider Sale: Director Richard Berman Sells 8,105 Shares of CryoPort Inc (CYRX) (GuruFocus.com) -7.39%
May-08-24 02:54PM	Cryoport, Inc. (NASDAQ:CYRX) Q1 2024 Earnings Call Transcript (Insider Monkey) -19.51%
04:03AM	CryoPort Inc (CYRX) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges with ... (GuruFocus.com)
May-07-24 09:56PM	CYRX Stock Earnings: CryoPort Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
06:18PM	CryoPort Inc (CYRX) Q1 2024 Earnings: Revenue Declines Amid Challenges, Yet Maintains Full-Year ... (GuruFocus.com)
04:08PM	Cryoport Reports First Quarter 2024 Financial Results (PR Newswire)
May-03-24 10:12AM	B. Riley Downgrades Cryoport to Neutral From Buy, Adjusts Price Target to $19 From $22 (MT Newswires) -7.05%
06:41AM	B. Riley Downgrades Cryoport to Neutral From Buy, Cuts Price Target to $19 From $22 (MT Newswires)
Apr-30-24 08:30AM	Cryoport to Report First Quarter 2024 Financial Results on May 7, 2024 (PR Newswire)
Apr-25-24 10:02AM	Earnings Preview: CryoPort, Inc. (CYRX) Q1 Earnings Expected to Decline (Zacks)
Mar-13-24 09:16AM	Cryoport, Inc. (NASDAQ:CYRX) Q4 2023 Earnings Call Transcript (Insider Monkey) -11.90%
Mar-12-24 05:52PM	CryoPort Inc (CYRX) Reports Mixed Financial Results Amidst Global Challenges (GuruFocus.com)
05:30PM	CryoPort, Inc. (CYRX) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Cryoport Reports Fourth Quarter and Full Year 2023 Financial Results (PR Newswire)
Feb-27-24 08:30AM	Cryoport to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024 (PR Newswire) +5.95%

CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.

ChairmanMr. Jerrell W. Shelton

Senior VPMr. Robert S. Stefanovich MS

Senior VP and Chief Digital & Technology OfficerMr. Edward J. Zecchini

Senior VP & Chief Scientific OfficerDr. Mark W. Sawicki Ph.D.

Vice President of Corporate Development & Investor RelationsMr. Thomas J. Heinzen

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ZECCHINI EDWARD J	Chief Digital and Tech Officer	Jun 11 '26	Option Exercise	4.80	33,600	161,280	143,319	Jun 12 06:38 PM
ZECCHINI EDWARD J	Chief Digital and Tech Officer	Jun 10 '26	Option Exercise	4.80	1,400	6,720	111,119	Jun 12 06:38 PM
ZECCHINI EDWARD J	Chief Digital and Tech Officer	Jun 11 '26	Sale	14.47	33,600	486,239	109,719	Jun 12 06:38 PM
ZECCHINI EDWARD J	Chief Digital and Tech Officer	Jun 10 '26	Sale	15.23	1,400	21,324	109,719	Jun 12 06:38 PM
EDWARD ZECCHINI	Officer	Jun 11 '26	Proposed Sale	14.47	33,600	486,239		Jun 11 04:09 PM
EDWARD ZECCHINI	Officer	Jun 10 '26	Proposed Sale	15.23	1,400	21,324		Jun 10 04:15 PM
STEFANOVICH ROBERT	Chief Financial Officer	Jun 04 '26	Sale	16.27	169,427	2,756,984	109,850	Jun 08 09:11 PM
Mandalam Ramkumar	Director	Jun 08 '26	Sale	15.44	23,214	358,452	67,894	Jun 08 09:05 PM
RAMKUMAR MANDALAM	Director	Jun 08 '26	Proposed Sale	15.44	23,214	358,452		Jun 08 04:17 PM
STEFANOVICH ROBERT	Officer	Jun 04 '26	Proposed Sale	16.50	169,427	2,795,546		Jun 03 04:35 PM
SHELTON JERRELL	President, CEO	Apr 21 '26	Option Exercise	1.87	104,007	194,493	1,230,614	Apr 23 08:00 PM
SHELTON JERRELL	President, CEO	Apr 06 '26	Option Exercise	1.87	50,000	93,500	1,126,607	Apr 08 06:32 PM
STEFANOVICH ROBERT	Chief Financial Officer	Mar 23 '26	Sale	8.18	1,094	8,949	279,277	Mar 25 08:01 PM
SHELTON JERRELL	President, CEO	Mar 23 '26	Option Exercise	1.87	25,000	46,750	1,076,607	Mar 25 08:00 PM
SHELTON JERRELL	President, CEO	Mar 23 '26	Sale	8.18	2,894	23,673	1,051,607	Mar 25 08:00 PM
Sawicki Mark W	Chief Scientific Officer	Mar 23 '26	Sale	8.18	1,341	10,969	102,356	Mar 25 08:00 PM
ZECCHINI EDWARD J	See Remarks	Mar 16 '26	Sale	8.00	2,014	16,112	109,719	Mar 17 08:01 PM
SHELTON JERRELL	President, CEO	Mar 16 '26	Sale	8.00	7,918	63,344	1,054,501	Mar 17 08:00 PM
Sawicki Mark W	Chief Scientific Officer	Mar 16 '26	Sale	8.00	3,235	25,880	103,697	Mar 17 08:00 PM
STEFANOVICH ROBERT	Chief Financial Officer	Mar 12 '26	Option Exercise	1.87	87,188	163,042	294,401	Mar 16 09:35 PM
STEFANOVICH ROBERT	Chief Financial Officer	Mar 12 '26	Sale	7.76	38,700	300,386	255,701	Mar 16 09:35 PM
STEFANOVICH ROBERT	Chief Financial Officer	Mar 16 '26	Sale	8.00	2,743	21,944	280,371	Mar 16 09:35 PM
ROBERT S. STEFANOVICH	Officer	Mar 12 '26	Proposed Sale	7.76	38,700	300,386		Mar 12 04:17 PM
Mandalam Ramkumar	Director	Dec 10 '25	Sale	9.99	11,570	115,540	80,758	Dec 12 05:30 PM
RAMKUMAR MANDALAM	Director	Dec 10 '25	Proposed Sale	9.99	11,570	115,540		Dec 10 04:10 PM
Hariri Robert J	Director	Sep 11 '25	Option Exercise	2.66	50,000	133,000	76,275	Sep 12 05:30 PM
Hariri Robert J	Director	Sep 11 '25	Sale	9.71	25,000	242,738	51,275	Sep 12 05:30 PM
ROBERT HARIRI	Director	Sep 11 '25	Proposed Sale	9.71	25,000	242,738		Sep 11 04:29 PM
Hariri Robert J	Director	Aug 22 '25	Sale	8.60	5,000	43,000	26,275	Aug 29 06:46 PM
STEFANOVICH ROBERT	Chief Financial Officer	Aug 19 '25	Option Exercise	3.07	26,164	80,323	216,513	Aug 21 05:00 PM
STEFANOVICH ROBERT	Chief Financial Officer	Aug 19 '25	Sale	8.67	9,300	80,618	207,213	Aug 21 05:00 PM
ROBERT S. STEFANOVICH	Officer	Aug 19 '25	Proposed Sale	8.67	9,300	80,618		Aug 19 04:40 PM
SHELTON JERRELL	President, CEO	Aug 13 '25	Option Exercise	5.00	25,000	125,000	1,062,419	Aug 15 05:00 PM
SHELTON JERRELL	President, CEO	Jul 31 '25	Option Exercise	5.00	25,000	125,000	1,037,419	Aug 04 06:00 PM
SHELTON JERRELL	President, CEO	Jul 24 '25	Option Exercise	5.00	25,000	125,000	1,012,419	Jul 28 05:04 PM
Mandalam Ramkumar	Director	Jul 22 '25	Option Exercise	3.07	60,000	184,200	133,056	Jul 24 05:00 PM
Mandalam Ramkumar	Director	Jul 22 '25	Sale	7.24	40,728	294,899	92,328	Jul 24 05:00 PM
SHELTON JERRELL	President, CEO	Jul 18 '25	Option Exercise	5.00	25,000	125,000	987,419	Jul 22 04:52 PM
RAMKUMAR MANDALAM	Director	Jul 22 '25	Proposed Sale	6.71	40,728	273,285		Jul 22 04:10 PM
SHELTON JERRELL	President, CEO	Jul 08 '25	Option Exercise	5.00	25,000	125,000	962,419	Jul 10 05:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

$100 Off Your First Year Get Elite For Just $199.50

CryoPort Inc

Upgrade your Finviz experience